Infinitas Capital

Einwert is a European company that modernizes real estate valuation through its hybrid appraiser platform. It leverages digital technology and sustainability insights to empower appraisers, enhance market transparency, and facilitate data-driven, future-oriented decisions for real estate investors.

Wonder Brands partners with successful digital brands in Latin America, investing significantly to boost growth. It provides value through technology, digital marketing, supply chain, administration support, enabling brands to expand reach and diversify products.

AmyriAD is a clinical-stage biopharmaceutical company focused on therapies for Alzheimer's disease. It is developing an orally administered small-molecule drug designed to enhance brain neurotransmission with the aim of improving cognition and functional independence in individuals affected by Alzheimer's disease.

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on redefining psychiatry through the integration of patient neurobiology into the drug development process. Utilizing an AI-enabled biomarker platform, the company combines diverse information about patients' brain activity and behavior to create personalized and effective treatment options. Alto Neuroscience is developing several clinical assets, including ALTO-100, ALTO-202, ALTO-101, and ALTO-300, primarily targeting depressive disorders and schizophrenia, identified through independent brain-based biomarkers. By moving away from traditional trial-and-error methods, the company aims to align its innovative therapies with the specific needs of patients, ultimately improving the management of mental health conditions.

HausVorteil operates a real estate platform offering financing solutions tailored to clients' needs. Services include partial property sales, land sales with building rights, residential rights transfers, traditional construction financing, leasing, and brokerage services.

Exporo is a German online real estate crowdfunding platform based in Hamburg that connects private investors with real estate developers seeking capital. Founded in 2014, it operates a marketplace that provides investment opportunities in real estate projects, aiming to democratize access by allowing retail investors to participate with small sums. The platform offers transparency and straightforward terms, facilitating direct capital flows between individuals and developers and enabling projects that were once available mainly to institutional investors.

Einwert is a European company that modernizes real estate valuation through its hybrid appraiser platform. It leverages digital technology and sustainability insights to empower appraisers, enhance market transparency, and facilitate data-driven, future-oriented decisions for real estate investors.

AMZSCALE specializes in comprehensive brand-building services for Amazon. Their team comprises experienced eCommerce experts who have successfully launched, grown, and sold their own Amazon brands. They offer end-to-end support, including product research, supplier sourcing, listing creation, fulfillment coordination, and advertising management.

FORME, founded in 2020 and based in Los Angeles, California, offers an integrated home fitness platform that focuses on sports and fitness instruction. The company provides interactive wellness and strength training sessions, allowing customers to engage in personalized workouts from the comfort of their homes. In addition to fitness training, FORME’s health coaching services include guidance on nutrition, recovery, sleep, and various lifestyle aspects. Revenue is generated through the sale of connected fitness products, membership fees, and personal training services, positioning FORME as a comprehensive solution for individuals seeking to enhance their fitness and overall well-being.

Storypod fosters children's love for learning via screen-free, interactive audio content. Its IoT platform delivers stage-based, adaptive educational materials, supporting early childhood cognitive development.

Cambrian BioPharma specializes in developing innovative therapeutics aimed at extending healthspan, the period of life spent in good health. As a Distributed Development Company (DisCo), it focuses on advancing scientific breakthroughs targeting biological drivers of aging, initially treating specific diseases and later deploying these interventions preventatively to enhance overall quality of life.

Customuse develops user-friendly software that enables individuals to design wearable AR outfits for virtual avatars. Users can sell these designs across popular games and social media platforms, promoting their brand and engaging with audiences.

Olsam Group is a commerce company that acquires and operates top Amazon third-party and other direct-to-consumer eCommerce brands. It employs a technology-driven approach, focusing on scaling acquired brands to achieve hypergrowth on global digital marketplaces.

Bullish Global is a new blockchain-based cryptocurrency exchange designed to combine the performance, user privacy, and compliance offered by central order book technology with the vertically integrated user benefits of decentralized finance (DeFi) market architecture.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

NextMarkets GmbH, founded in 2014 and based in Cologne, Germany, offers a user-friendly web and mobile application tailored for private investors engaging in capital markets. The platform allows users to trade a wide range of financial instruments, including contracts for difference (CFDs) on equities, foreign exchange, bonds, and commodities. Recognizing that a significant majority of private investors struggle in the stock market due to behavioral economic factors, NextMarkets aims to empower its users by providing educational resources, training, and strategies that enhance their trading experience. The company's mission is to promote a more informed and sustainable approach to investing, enabling users to better understand market dynamics and make informed trading decisions.

Cambrian BioPharma specializes in developing innovative therapeutics aimed at extending healthspan, the period of life spent in good health. As a Distributed Development Company (DisCo), it focuses on advancing scientific breakthroughs targeting biological drivers of aging, initially treating specific diseases and later deploying these interventions preventatively to enhance overall quality of life.

Sensei Biotherapeutics is a clinical-stage biotechnology company developing next-generation cancer immunotherapies. It focuses on novel biologics that modulate the immune system to treat cancers with unmet need, using its ImmunoPhage discovery platform to study the tumor microenvironment and identify differentiated mechanisms that engage both innate and adaptive immunity. The company pursues a Tumor Microenvironment Activated Biologics TMAb platform to selectively disable immunosuppressive signals or activate immunostimulatory signals within the tumor microenvironment. Headquartered in Gaithersburg, Maryland with an office in Boston, Massachusetts, Sensei Biotherapeutics has four investigational product candidates in development: SNS-101, SNS-102, SNS-103, and SNS-201.

Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.

Booster Therapeutics is a biotechnology company focused on developing drug modalities to regulate cellular homeostasis and eliminate toxic accumulations. Its primary goal is to reinstate balance within cells, enabling the prevention and treatment of diseases associated with aging.

ATAI Life Sciences is a biotechnology company focused on developing therapies for mental health disorders, leveraging psychedelic compounds and neuroscience-based approaches. It operates a platform for mental health drug discovery and development and collaborates with partners and research institutions to advance its pipeline, which includes VLS-01, a buccal-film DMT candidate for treatment-resistant depression, and EMP-01, an oral MDMA therapy for social anxiety disorder, along with a drug discovery program aimed at identifying non-hallucinogenic 5-HT2A receptor agonists for depression. The company is based in Munich, Germany, with additional offices in Berlin and London.